These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 23940081)

  • 1. The emerging role of SOX2 in cell proliferation and survival and its crosstalk with oncogenic signaling in lung cancer.
    Chou YT; Lee CC; Hsiao SH; Lin SE; Lin SC; Chung CH; Chung CH; Kao YR; Wang YH; Chen CT; Wei YH; Wu CW
    Stem Cells; 2013 Dec; 31(12):2607-19. PubMed ID: 23940081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SOX2 plays a critical role in EGFR-mediated self-renewal of human prostate cancer stem-like cells.
    Rybak AP; Tang D
    Cell Signal; 2013 Dec; 25(12):2734-42. PubMed ID: 24036214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galectin-3 modulates the EGFR signalling-mediated regulation of Sox2 expression via c-Myc in lung cancer.
    Kuo HY; Hsu HT; Chen YC; Chang YW; Liu FT; Wu CW
    Glycobiology; 2016 Feb; 26(2):155-65. PubMed ID: 26447186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated epidermal growth factor receptor-Stat-3 signaling promotes tumor survival in vivo in non-small cell lung cancer.
    Haura EB; Zheng Z; Song L; Cantor A; Bepler G
    Clin Cancer Res; 2005 Dec; 11(23):8288-94. PubMed ID: 16322287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gli1-Mediated Regulation of Sox2 Facilitates Self-Renewal of Stem-Like Cells and Confers Resistance to EGFR Inhibitors in Non-Small Cell Lung Cancer.
    Bora-Singhal N; Perumal D; Nguyen J; Chellappan S
    Neoplasia; 2015 Jul; 17(7):538-51. PubMed ID: 26297432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Akt kinase-interacting protein1, a novel therapeutic target for lung cancer with EGFR-activating and gatekeeper mutations.
    Yamada T; Takeuchi S; Fujita N; Nakamura A; Wang W; Li Q; Oda M; Mitsudomi T; Yatabe Y; Sekido Y; Yoshida J; Higashiyama M; Noguchi M; Uehara H; Nishioka Y; Sone S; Yano S
    Oncogene; 2013 Sep; 32(37):4427-35. PubMed ID: 23045273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of a putative tumor suppressor BMP4 by SOX2 promotes growth of lung squamous cell carcinoma.
    Fang WT; Fan CC; Li SM; Jang TH; Lin HP; Shih NY; Chen CH; Wang TY; Huang SF; Lee AY; Liu YL; Tsai FY; Huang CT; Yang SJ; Yen LJ; Chuu CP; Chen CY; Hsiung CA; Chang JY; Wang LH; Chang IS; Jiang SS
    Int J Cancer; 2014 Aug; 135(4):809-19. PubMed ID: 24477565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SOX2 regulates apoptosis through MAP4K4-survivin signaling pathway in human lung cancer cells.
    Chen S; Li X; Lu D; Xu Y; Mou W; Wang L; Chen Y; Liu Y; Li X; Li LY; Liu L; Stupack D; Reisfeld RA; Xiang R; Li N
    Carcinogenesis; 2014 Mar; 35(3):613-23. PubMed ID: 24233838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sox2 inhibits Wnt-β-catenin signaling and metastatic potency of cisplatin-resistant lung adenocarcinoma cells.
    He J; Shi J; Zhang K; Xue J; Li J; Yang J; Chen J; Wei J; Ren H; Liu X
    Mol Med Rep; 2017 Apr; 15(4):1693-1701. PubMed ID: 28259951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-talk between SOX2 and TGFβ Signaling Regulates EGFR-TKI Tolerance and Lung Cancer Dissemination.
    Kuo MH; Lee AC; Hsiao SH; Lin SE; Chiu YF; Yang LH; Yu CC; Chiou SH; Huang HN; Ko JC; Chou YT
    Cancer Res; 2020 Oct; 80(20):4426-4438. PubMed ID: 32816907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of CABYR-a/b increases chemosensitivity of human non-small cell lung cancer cells through inactivation of Akt.
    Qian Z; Li M; Wang R; Xiao Q; Wang J; Li M; He D; Xiao X
    Mol Cancer Res; 2014 Mar; 12(3):335-47. PubMed ID: 24362251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FGFR1-ERK1/2-SOX2 axis promotes cell proliferation, epithelial-mesenchymal transition, and metastasis in FGFR1-amplified lung cancer.
    Wang K; Ji W; Yu Y; Li Z; Niu X; Xia W; Lu S
    Oncogene; 2018 Sep; 37(39):5340-5354. PubMed ID: 29858603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β1 integrin controls EGFR signaling and tumorigenic properties of lung cancer cells.
    Morello V; Cabodi S; Sigismund S; Camacho-Leal MP; Repetto D; Volante M; Papotti M; Turco E; Defilippi P
    Oncogene; 2011 Sep; 30(39):4087-96. PubMed ID: 21478906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FoxM1 Promotes Stemness and Radio-Resistance of Glioblastoma by Regulating the Master Stem Cell Regulator Sox2.
    Lee Y; Kim KH; Kim DG; Cho HJ; Kim Y; Rheey J; Shin K; Seo YJ; Choi YS; Lee JI; Lee J; Joo KM; Nam DH
    PLoS One; 2015; 10(10):e0137703. PubMed ID: 26444992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SOX2 promotes chemoresistance, cancer stem cells properties, and epithelial-mesenchymal transition by β-catenin and Beclin1/autophagy signaling in colorectal cancer.
    Zhu Y; Huang S; Chen S; Chen J; Wang Z; Wang Y; Zheng H
    Cell Death Dis; 2021 May; 12(5):449. PubMed ID: 33953166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of the Bcl-2 gene increases sensitivity to EGFR tyrosine kinase inhibitors in the H1975 lung cancer cell line harboring T790M mutation.
    Zou M; Xia S; Zhuang L; Han N; Chu Q; Chao T; Peng P; Chen Y; Gui Q; Yu S
    Int J Oncol; 2013 Jun; 42(6):2094-102. PubMed ID: 23588221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The FBXW2-MSX2-SOX2 axis regulates stem cell property and drug resistance of cancer cells.
    Yin Y; Xie CM; Li H; Tan M; Chen G; Schiff R; Xiong X; Sun Y
    Proc Natl Acad Sci U S A; 2019 Oct; 116(41):20528-20538. PubMed ID: 31548378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysine-specific demethylase KDM3A regulates ovarian cancer stemness and chemoresistance.
    Ramadoss S; Sen S; Ramachandran I; Roy S; Chaudhuri G; Farias-Eisner R
    Oncogene; 2017 Mar; 36(11):1537-1545. PubMed ID: 27694900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF.
    Chou YT; Lin HH; Lien YC; Wang YH; Hong CF; Kao YR; Lin SC; Chang YC; Lin SY; Chen SJ; Chen HC; Yeh SD; Wu CW
    Cancer Res; 2010 Nov; 70(21):8822-31. PubMed ID: 20978205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex determining region Y-box 2 inhibits the proliferation of colorectal adenocarcinoma cells through the mTOR signaling pathway.
    Liu H; Du L; Wen Z; Yang Y; Li J; Dong Z; Zheng G; Wang L; Zhang X; Wang C
    Int J Mol Med; 2013 Jul; 32(1):59-66. PubMed ID: 23599173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.